OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
May 28, 2024
Results from the CORE-001 clinical trial are expected to be presented at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting.
Among its benefits, the fund will provide up to $8,000 in medication copayment or insurance premium assistance.
The latest news for pharma industry insiders.
May 27, 2024
The transaction serves as way to expand customers’ access to products and capabilities.
May 24, 2024
The deal grows it pipeline, powered by panCAR programs in autoimmune disease and oncology.
With the acquisition, Merck’s US and Canada life science business aims to further increase its viral vector manufacturing capabilities.
May 23, 2024
The CDMO will run the active pharmaceutical ingredient pilot plant in Sandwich, UK, along with development laboratories.
The deal features felzartamab, an investigational anti-CD38 monoclonal antibody, whose clinical outcomes have shown potential to tackle various immune-mediated diseases.